J&J Takes Leaner, But Stronger Business Approach With Management Consolidation
This article was originally published in The Pink Sheet Daily
Executive Summary
The health care giant is eliminating some management positions with more organizational announcements expected in coming weeks.
You may also be interested in...
J&J Wants Comparative Effectiveness Studies on Long-Acting Anti-Psychotics
The Institute of Medicine's report on CE priorities, to be released June 30, may shape agenda across a number of product categories.
J&J Pharma Presents a Robust Pipeline and Outlines A New R&D Structure
In a wide-ranging presentation to Wall Street, the company highlights key new products in development and an R&D strategy built around five therapeutic areas.
J&J Reorganizes Again; Scodari Announces Retirement, Poon Will Take Over
In its latest restructuring move, announced Nov. 15, Johnson & Johnson - a model for diversified health care companies - is focusing on providing integrated health solutions rather than individual products